Bio-Path (NASDAQ:BPTH) is scheduled to be posting its quarterly earnings results before the market opens on Thursday, May 16th.
Shares of BPTH opened at $15.97 on Monday. Bio-Path has a 1-year low of $1.61 and a 1-year high of $73.52.
ILLEGAL ACTIVITY WARNING: “Bio-Path (BPTH) Scheduled to Post Earnings on Thursday” was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another domain, it was copied illegally and reposted in violation of US and international copyright legislation. The original version of this news story can be viewed at https://www.americanbankingnews.com/2019/05/13/bio-path-bpth-scheduled-to-post-earnings-on-thursday.html.
Bio-Path Company Profile
Bio-Path Holdings, Inc operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction.
Read More: What is net income?
Receive News & Ratings for Bio-Path Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Path and related companies with MarketBeat.com's FREE daily email newsletter.